Introduction and hypothesis The primary aim was to characterize stress urinary incontinence (SUI) symptom distress and impact after a midurethral sling (MUS) in women ≥70 compared to women <70 years of age. Methods A retrospective cohort study of women undergoing a primary MUS was conducted. The primary outcome was SUI symptoms defined as either "moderately" or "quite a bit" responses to ≥1 of the two SUI questions of the Pelvic Floor Distress Inventory-20 (PFDI-20). Urgency urinary incontinence (UUI) was defined as either moderately or quite a bit responses to the UUI question of the PFDI-20. The Pelvic Floor Impact Questionnaire (PFIQ-7), Patient Satisfaction Questionnaire (PSQ), and Patient Global Impression of Improvement (PGI-I) questionnaires were also administered. Results The mean age of patients ≥70 years (n=160) was 75.4 ±4.5 and <70 years (n=536) was 56.2±9.4. Multivariable analysis revealed no difference in SUI failure rates in older compared to younger cohorts, adjusted odds ratio (OR) 1.7, 95 % confidence interval (CI) 0.9-3.1. Women <70 demonstrated greater improvement in urinary incontinence (UI) symptom impact [−20.4 (33.0) vs −12.2 (30.7), p=0.01] and women ≥70 had greater persistent UUI symptoms (31.5 vs 23.3 %, p=0.04); there was no difference between cohorts in resolution of UUI (29.6 vs 34.2 %, p=0.34). Younger women reported a greater impression of improvement compared to older women (67.7 vs 56.6 %, p=0.01, respectively). Conclusions Older and younger women have similar SUI outcomes after MUS; however, older women have more persistent UUI and a worse impression of improvement of their urinary tract condition.
Introduction
Stress urinary incontinence (SUI), which affects up to 35 % of women, is the involuntary leakage of urine with increases in abdominal pressures [1, 2] . While SUI can be treated both nonsurgically and surgically, the only documented long-term curative treatment is surgery. The most common surgical treatment performed in the USA is the midurethral sling (MUS) procedure with more than 103,000 procedures performed annually [3, 4] . MUS is now considered the gold standard for SUI treatment and success rates of these procedures at 12 months range from 77 to 90 %, reflecting differences in definition of success [4] . As a result of the high prevalence of SUI and large number of MUS procedures performed each year, the procedure is performed on women over a wide range of ages.
The effect of the age of the patient and outcome of a MUS procedure is a characteristic that has not been well characterized. A study of 1,356 sling procedures on women age 65 and older stratified patients by age into two groups, one less than 75 years of age and the other 75 years of age and older. Results demonstrated o b j e c t i v e o u t c o m e s i n y o u n g e r w o m e n w e r e significantly better with respect to postoperative urgency urinary incontinence (UUI) (20.0 vs 12.6 %), treatment failure (10.5 vs 7.2 %), and outlet obstruction (10.5 vs 6.6 %) after MUS [5] .
Given the general paucity of data on age-related effects for outcomes of MUS on SUI and UUI, our primary aim was to characterize SUI and UUI symptom distress and impact outcomes after a primary MUS using validated measures in women≥70 (older women) compared to women<70 (younger women). Differences in de novo and persistent UUI, patient satisfaction, and patient impression of improvement were also characterized. We hypothesized that older women undergoing primary MUS for SUI would have worse outcomes compared to younger women with regard to cure rate and satisfaction. This current study was a secondary analysis utilizing an established database from a previously published primary analysis by Parden et al. [6] . Women included in our study were those with no history of prior MUS procedure and minimum follow-up was 12 months. Women undergoing primary MUS were separated into two cohorts: women<70 (younger women) and women≥70 (older women). tension-free vaginal tape. The transobturator MUS used as originally described [7, 8] . Procedures were performed by four attending urogynecology surgeons during the study period. The data were not extracted by the surgeons and were entered into a password-protected database that was inaccessible to the surgeons.
Materials and methods

A
The primary symptom distress outcome for SUI was defined as either a "moderately" or "quite a bit" response to at least one of the two SUI questions on the Urogenital Distress Inventory (UDI) subscale of the Pelvic Floor Distress Inventory-20 (PFDI-20): "Do you usually experience urine leakage related to laughing, coughing, or sneezing?" and "Do you usually experience small amounts of urine leakage (that is, drops)?" [9] . "Cure" of SUI was defined by an answer of "not at all" or "somewhat" to both of the above questions.
UUI was defined at baseline and follow-up as either "moderately" or "quite a bit" responses to the UDI subscale UUI question: "Do you usually experience urine leakage associated with a feeling of urgency, that is, a strong sensation of need to go to the bathroom?" [9] . Resolution of de novo UUI and persistent UUI were evaluated and compared between cohorts. Patients were considered to have resolution of UUI symptoms by responding "no" or "not at all" to the UUI question of the PFDI-20 postoperatively. Patients were considered to have de novo UUI if they answered "no", "not at all", or "somewhat" in response to the UUI, PFDI-20 question at baseline and answered "moderately" or "quite a bit" postoperatively. Persistent UUI symptoms were defined as having baseline and postoperative moderately or quite a bit responses on the UUI subscale question. Symptom-specific effect on quality of life (QOL) was assessed using the Urinary Impact Questionnaire (UIQ) subscale of the PFIQ-7.
Patient impression of improvement was assessed with the Patient Global Impression of Improvement Questionnaire (PGI-I) and patient satisfaction was assessed with the Patient Satisfaction Questionnaire (PSQ) [10, 11] . The PGI-I consists of a single question: "Circle the one response that best describes how your urinary tract condition is now, compared to how it was before you had surgery." There are seven possible responses ranging from "very much better" to "very much worse," and improvement was defined as "very much/much better." The PSQ consists of a single question: "How satisfied are you with your progress since your surgery?" in which the three possible responses are "completely satisfied," "somewhat satisfied," and "not satisfied" where satisfaction was defined as "completely/somewhat" [10, 11] .
All questionnaires were collected preoperatively (except the PGI-I and PSQ) and again at follow-up and were scored using published protocols. Student's t test, Wilcoxon rank sum test, chi-square test, and Fisher's exact test were used to compare outcomes between the two age groups. Multivariable regression analyses were performed controlling for baseline UUI symptoms, obesity, medical comorbidities, tobacco use, prior hysterectomy, vaginal estrogen use, concurrent prolapse surgery, and Valsalva leak point pressures (VLPP). All tests of significance were evaluated at a 0.05 level of significance. SAS v9.2 (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses.
Results
A total of 707 women were eligible for this analysis and 696 had complete follow-up responses for SUI and UUI from the PFDI-20. The mean age of patients in the older group (n= 160), ≥ 70 years old, was 75.4±4.5, and the mean age of patients in the younger group (n=536), < 70 years old, was 56.2 ± 9.4. There was no difference in mean follow-up 832 Int Urogynecol J (2015) 26:831-835
The retropubic MUS used was the Gynecare® was the Monarc®. All sling procedures were performed between the groups (37.6±16.5 months for women<70 and 37.2±16.2 months for women≥70, p=0.81).
Women in the older age group had significantly higher proportions of medical comorbidities including hypertension, diabetes mellitus, osteoporosis, and chronic obstruction pulmonary disease (70.6 vs 50.8 %, p<0.0001). In addition, women in the older cohort had a significantly higher number of prescription medications, vaginal estrogen use, history of prior hysterectomy, and prior surgery for repair of pelvic organ prolapse (Table 1) . Regarding the lower urinary tract, older women had significantly higher anticholinergic use for overactive bladder (13.2 vs 7.7 %, p=0.031), detrusor overactivity (23.4 vs 10.7 %, p=0.0004), and lower median, range, and baseline VLPP [88.5 (70.7-115.7) vs 110 (86-139.7) cmH 2 O, p<0.0001] compared to younger women. Further, there were no differences in baseline UDI symptom distress or impact scores between older and younger women; however, a significantly higher proportion of older women had baseline UUI symptoms (64.1 vs 51.4 %, p=0.01). Other clinical and demographic factors are noted in Table 1 .
There was no difference in unadjusted SUI failure rates between age-stratified cohorts, 27.4 % in younger women vs 33.1 % in older women, p=0.16. Multivariable analysis controlling for baseline UUI, obesity, comorbidities (hypertension, diabetes mellitus, osteoporosis, and chronic obstructive pulmonary disease), smoking, hysterectomy, vaginal estrogen use, concurrent prolapse surgery, and VLPP revealed no difference in primary SUI failure rates in older women compared to younger women, adjusted odds ratio (OR) 1.7, 95 % confidence interval (CI) 0.9-3.1, p=0.09. Younger women demonstrated greater improvement in urinary impact with a greater decrease in PFIQ-7 score (−20.4±33 vs −12.2±30.7, p= 0.01); however, there was no difference in symptom distress improvement between younger and older women (−23.9± 30.1 vs −19.4±31.0, p=0.14, respectively).
There was no significant difference in de novo symptoms (7.5 % in younger vs 4.3 % in older women, p=0.22), or in resolution of UUI symptoms (29.6 % in younger vs 34.2 % in older women, p=0.34), between the age groups after primary MUS. There was a significant difference in persistent UUI symptoms in the older group (31.5 vs 23.3 %, p=0.04).
There was no difference in the proportion of subjects reporting postoperative satisfaction between the cohorts according to the PSQ (83.2 % in younger women vs 77.0 % in older women, p=0.08). However, younger women reported a greater global impression of improvement of their urinary tract condition postoperatively as compared to older women (67.7 vs 56.6 %, p=0.01).
Discussion
In these well-characterized cohorts of older and younger women, SUI outcomes measured using a robust and validated patient-reported outcome measure and controlling for potential confounding variables were similar, after a primary MUS procedure. In this study, younger women did report a greater impression of improvement of their urinary tract condition after surgery.
Our findings are similar to a recent study in which 1,225 women undergoing MUS procedures (955 retropubic, 270 transobturator), stratified by age (women greater than or equal to 80 and women less than 80), found no significant difference in cure rate, long-term rate of voiding difficulty, or rate of de novo urgency incontinence using subjective outcome measures. In this study, multivariate analysis did not demonstrate age to be an independent predictor of sling failure [12] .
The improvements in the UDI scores of both the older and the younger women cohorts exceeded the minimum important differences (MID) (11 points); however, only the younger women met the MID for the UIQ score (16 points) [13] . This finding may explain the differences noted between the cohorts in impression of improvement and may reflect inherent differences between younger and older women presenting for primary MUS procedures. Though not directly addressed in this study, it is conceivable that younger women, despite similar baseline UDI and UIQ scores to older women, report a greater sense of improvement because they have been suffering from their urinary tract conditions less than older women.
Although subjective cure may be similar between cohorts, there may be significant differences in objective outcomes in older women. Nager et al. demonstrated that women with baseline VLPP in the lowest quartile (VLPP<86 cmH 2 0) have a nearly twofold increased odds of objective failure after MUS, regardless of MUS route, transobturator or retropubic approach [14] . Our data demonstrated that, at baseline, older women presenting for primary MUS did have a significantly lower VLLP than younger women. Furthermore, the baseline VLLP in our cohort of older women closely approximated the previously reported lowest quartile. It is unclear which factors are directly reflected by the patients' responses, but they likely involve physiological, social, and psychological interactions. It is important to note that while younger women reported a greater impression of improvement, there was no difference in the proportion of subjects reporting postoperative satisfaction between the age groups. This suggests that both groups may have had similar degrees of improvement within the context of their postoperative expectations and activity levels.
Older women had a significantly higher proportion of baseline UUI symptoms, and while there were no differences between the age groups in resolution of UUI symptoms or de novo UUI after primary MUS, there was a significantly greater persistence of UUI symptoms in older women. These findings could be due to worse symptoms at baseline in older women including a significantly higher proportion of older women at baseline with detrusor overactivity and may also contribute to a lower global impression of improvement.
Limitations of the study include those inherent to a retrospective cohort design, as well as incomplete medical records and nonresponder bias inherent in the primary acquisition of data [6] . Despite these limitations, the study was strengthened by clear and robust validated outcome measures and a large sample size.
Older and younger women have similar SUI outcomes after primary MUS; however, older women have more persistent UUI symptoms and a worse impression of improvement in their urinary tract condition following primary MUS as compared to younger women. As population demographics continue to evolve, specifics on age-related outcomes of urinary incontinence interventions deserve further investigation. This information will be helpful for providing more robust patient counseling to all women regarding expectations of surgical intervention for SUI.
